Millions of Americans take medications known as proton pump inhibitors every day to treat heartburn and acid reflux. In recent years, these drugs have been linked to a greater risk of kidney failure, stroke, and early death. New research suggests there may also be a higher risk of dementia.

The US supreme court has agreed to hear a challenge to the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement that would shield its owners, the Sackler family, from lawsuits over their role in America’s opioid epidemic.

A new study has found that the U.S. state of Kentucky's 2007 lawsuit against Purdue Pharma dissuaded only Purdue's opioid marketing. The promotion of opioids by competing drug companies actually increased.

Studies estimate that up to three in every 100 patients who undergo chemotherapy will suffer permanent hair loss. And long-term alopecia – as it is medically known – is listed on official guidance for doctors as a side effect of chemo to warn patients about.

An analysis has found that the use of low-dose aspirin is associated with a 20 percent increased incidence of anemia and decline in ferritin, or blood iron levels, in otherwise healthy older adults.

You might not have heard it in the news, but in recent months Pfizer’s pharmacovigilance documents requested by the European Union’s drug regulator, the European Medicines Agency, have been released. They show that Pfizer knew about a sickening level of injury early on.

Pfizer has reportedly funneled a whopping $12 million dollars into the bank account of CNN host Anderson Cooper as part of a deal to promote the company’s toxic mRNA jabs to the American public.

The Sackler family, the wealthy owners of Purdue Pharma, will be shielded from future lawsuits related to the opioid epidemic under a plan approved by a U.S. federal appeals court.